Literature DB >> 24213971

Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits.

Wen-Yi Lo1, Andre H Lagrange, Ciria C Hernandez, Katharine N Gurba, Robert L Macdonald.   

Abstract

GABAA receptors, the major mediators of fast inhibitory neuronal transmission, are heteropentameric glycoproteins assembled from a panel of subunits, usually including α and β subunits with or without a γ2 subunit. The α1β2γ2 receptor is the most abundant GABAA receptor in brain. Co-expression of γ2 with α1 and β2 subunits causes conformational changes, increases GABAA receptor channel conductance, and prolongs channel open times. We reported previously that glycosylation of the three β2 subunit glycosylation sites, N32, N104 and N173, was important for α1β2 receptor channel gating. Here, we examined the hypothesis that steric effects or conformational changes caused by γ2 subunit co-expression alter the glycosylation of partnering β2 subunits. We found that co-expression of γ2 subunits hindered processing of β2 subunit N104 N-glycans in HEK293T cells. This γ2 subunit-dependent effect was strong enough that a decrease of γ2 subunit expression in heterozygous GABRG2 knockout (γ2(+/-)) mice led to appreciable changes in the endoglycosidase H digestion pattern of neuronal β2 subunits. Interestingly, as measured by flow cytometry, γ2 subunit surface levels were decreased by mutating each of the β2 subunit glycosylation sites. The β2 subunit mutation N104Q also decreased GABA potency to evoke macroscopic currents and reduced conductance, mean open time and open probability of single channel currents. Collectively, our data suggested that γ2 subunits interacted with β2 subunit N-glycans and/or subdomains containing the glycosylation sites, and that γ2 subunit co-expression-dependent alterations in the processing of the β2 subunit N104 N-glycans were involved in altering the function of surface GABAA receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24213971      PMCID: PMC4018433          DOI: 10.1007/s11064-013-1187-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database.

Authors:  R Apweiler; H Hermjakob; N Sharon
Journal:  Biochim Biophys Acta       Date:  1999-12-06

2.  GABA(A) receptor assembly. Identification and structure of gamma(2) sequences forming the intersubunit contacts with alpha(1) and beta(3) subunits.

Authors:  T Klausberger; K Fuchs; B Mayer; N Ehya; W Sieghart
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

3.  Subunit arrangement of gamma-aminobutyric acid type A receptors.

Authors:  S W Baumann; R Baur; E Sigel
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

4.  Effects of gamma2S subunit incorporation on GABAA receptor macroscopic kinetics.

Authors:  A J Boileau; T Li; C Benkwitz; C Czajkowski; R A Pearce
Journal:  Neuropharmacology       Date:  2003-06       Impact factor: 5.250

5.  GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.

Authors:  Katharine N Gurba; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

6.  Modulation of spontaneous and GABA-evoked tonic alpha4beta3delta and alpha4beta3gamma2L GABAA receptor currents by protein kinase A.

Authors:  Xin Tang; Ciria C Hernandez; Robert L Macdonald
Journal:  J Neurophysiol       Date:  2009-11-25       Impact factor: 2.714

Review 7.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

8.  Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes.

Authors:  Julie T Castaneda; Airi Harui; Sylvia M Kiertscher; Jeffrey D Roth; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-10       Impact factor: 4.147

Review 9.  Mutations in GABAA receptor subunits associated with genetic epilepsies.

Authors:  Robert L Macdonald; Jing-Qiong Kang; Martin J Gallagher
Journal:  J Physiol       Date:  2010-03-22       Impact factor: 5.182

10.  Charged residues in the beta2 subunit involved in GABAA receptor activation.

Authors:  Thomas L Kash; Maria-Johanna F Dizon; James R Trudell; Neil L Harrison
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  5 in total

1.  Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.

Authors:  Xuan Huang; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  Neurobiol Dis       Date:  2014-05-04       Impact factor: 5.996

2.  De novo GABRG2 mutations associated with epileptic encephalopathies.

Authors:  Dingding Shen; Ciria C Hernandez; Wangzhen Shen; Ningning Hu; Annapurna Poduri; Beth Shiedley; Alex Rotenberg; Alexandre N Datta; Steffen Leiz; Steffi Patzer; Rainer Boor; Kerri Ramsey; Ethan Goldberg; Ingo Helbig; Xilma R Ortiz-Gonzalez; Johannes R Lemke; Eric D Marsh; Robert L Macdonald
Journal:  Brain       Date:  2016-11-17       Impact factor: 13.501

3.  Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.

Authors:  Vaishali S Janve; Ciria C Hernandez; Kelienne M Verdier; Ningning Hu; Robert L Macdonald
Journal:  Ann Neurol       Date:  2016-05       Impact factor: 10.422

4.  GABA A Receptor Coupling Junction and Pore GABRB3 Mutations are Linked to Early-Onset Epileptic Encephalopathy.

Authors:  Ciria C Hernandez; Yujia Zhang; Ningning Hu; Dingding Shen; Wangzhen Shen; Xiaoyan Liu; Weijing Kong; Yuwu Jiang; Robert L Macdonald
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

5.  Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.

Authors:  Ciria C Hernandez; Tara L Klassen; Laurel G Jackson; Katharine Gurba; Ningning Hu; Jeffrey L Noebels; Robert L Macdonald
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.